<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35331679</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>11</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>16</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1872-7786</ISSN><JournalIssue CitedMedium="Internet"><Volume>358</Volume><PubDate><Year>2022</Year><Month>May</Month><Day>01</Day></PubDate></JournalIssue><Title>Chemico-biological interactions</Title><ISOAbbreviation>Chem Biol Interact</ISOAbbreviation></Journal><ArticleTitle>Gut Microbiota Disruption in COVID-19 or Post-COVID Illness Association with severity biomarkers: A Possible Role of Pre / Pro-biotics in manipulating microflora.</ArticleTitle><Pagination><StartPage>109898</StartPage><MedlinePgn>109898</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.cbi.2022.109898</ELocationID><ELocationID EIdType="pii" ValidYN="Y">S0009-2797(22)00103-X</ELocationID><Abstract><AbstractText>Coronavirus disease (COVID-19), a coronavirus-induced illness attributed to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) transmission, is thought to have first emerged on November 17, 2019. According to World Health Organization (WHO). COVID-19 has been linked to 379,223,560 documented occurrences and 5,693,245 fatalities globally as of 1st Feb 2022. Influenza A virus that has also been discovered diarrhea and gastrointestinal discomfort was found in the infected person, highlighting the need of monitoring them for gastro intestinal tract (GIT) symptoms regardless of whether the sickness is respiration related. The majority of the microbiome in the intestines is Firmicutes and Bacteroidetes, while Bacteroidetes, Proteobacteria, and Firmicutes are found in the lungs. Although most people overcome SARS-CoV-2 infections, many people continue to have symptoms months after the original sickness, called Long-COVID or Post COVID. The term "post-COVID-19 symptoms" refers to those that occur with or after COVID-19 and last for more than 12 weeks (long-COVID-19). The possible understanding of biological components such as inflammatory, immunological, metabolic activity biomarkers in peripheral blood is needed to evaluate the study. Therefore, this article aims to review the informative data that supports the idea underlying the disruption mechanisms of the microbiome of the gastrointestinal tract in the acute COVID-19 or post-COVID-mediated elevation of severity biomarkers.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Elsevier B.V. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alharbi</LastName><ForeName>Khalid Saad</ForeName><Initials>KS</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Al-Jouf, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Yogendra</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Maharishi Arvind College of Pharmacy, Ambabari Circle, Ambabari, Jaipur, 302023, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hassan Almalki</LastName><ForeName>Waleed</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rawat</LastName><ForeName>Sushama</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical Sciences, Jaipur National University, Jagatpura, Jaipur, India; Institute of Pharmacy, Nirma University, S.G.Highway, Ahmedabad, 382481, Gujarat,India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afzal</LastName><ForeName>Obaid</ForeName><Initials>O</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, 11942, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alfawaz Altamimi</LastName><ForeName>Abdulmalik Saleh</ForeName><Initials>AS</Initials><AffiliationInfo><Affiliation>Department of Pharmaceutical Chemistry, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al Kharj, 11942, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kazmi</LastName><ForeName>Imran</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Abbasi</LastName><ForeName>Fahad A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alzarea</LastName><ForeName>Sami I</ForeName><Initials>SI</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, College of Pharmacy, Jouf University, Sakaka, Al-Jouf, Saudi Arabia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Singh</LastName><ForeName>Sachin Kumar</ForeName><Initials>SK</Initials><AffiliationInfo><Affiliation>School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bhatt</LastName><ForeName>Shvetank</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Amity Institute of Pharmacy, Amity University Madhya Pradesh (AUMP), Gwalior, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chellappan</LastName><ForeName>Dinesh Kumar</ForeName><Initials>DK</Initials><AffiliationInfo><Affiliation>Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dua</LastName><ForeName>Kamal</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, Ultimo, NSW 2007, Australia; Faculty of Health, Australian Research Centre in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW 2007, Australia. Electronic address: kamalpharmacist@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gupta</LastName><ForeName>Gaurav</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, School of Pharmacy, Suresh Gyan Vihar University, Mahal Road, Jagatpura, Jaipur, India; Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences, Saveetha University, Chennai, India. Electronic address: gauravpharma25@gmail.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>Ireland</Country><MedlineTA>Chem Biol Interact</MedlineTA><NlmUniqueID>0227276</NlmUniqueID><ISSNLinking>0009-2797</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005767" MajorTopicYN="Y">Gastrointestinal Diseases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bacteroides species</Keyword><Keyword MajorTopicYN="N">Inflammatory cytokines</Keyword><Keyword MajorTopicYN="N">Lectin RegIII beta</Keyword><Keyword MajorTopicYN="N">Microbiota</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList><CoiStatement>The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>2</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>3</Month><Day>26</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>3</Month><Day>25</Day><Hour>5</Hour><Minute>34</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>3</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35331679</ArticleId><ArticleId IdType="pmc">PMC8934739</ArticleId><ArticleId IdType="doi">10.1016/j.cbi.2022.109898</ArticleId><ArticleId IdType="pii">S0009-2797(22)00103-X</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>The L. Emerging understandings of 2019-nCoV. Lancet. 2020;395:311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7134625</ArticleId><ArticleId IdType="pubmed">31986259</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh Y., Gupta G., Mishra A., Chellappan D.K., Dua K. Gender and age differences reveal risk patterns in COVID-19 outbreak. Alternative Ther. Health Med. 2020;26:54&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pubmed">32412919</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh Y., Gupta G., Satija S., Negi P., Chellappan D.K., Dua K. RAAS blockers in hypertension posing a higher risk toward the COVID-19. Dermatol. Ther. 2020;33 e13501-e13501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267235</ArticleId><ArticleId IdType="pubmed">32359088</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh Y., Ali H., Alharbi K.S., Almalki W.H., Kazmi I., Al-Abbasi F.A., Anand K., Dureja H., Singh S.K., Thangavelu L., Chellappan D.K., Dua K., Gupta G. Drug Dev Res.; 2021. Calcium Sensing Receptor Hyperactivation through Viral Envelop Protein E of SARS CoV2: A Novel Target for Cardio-Renal Damage in COVID-19 Infection.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8250664</ArticleId><ArticleId IdType="pubmed">33687087</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh Y., Gupta G., Anand K., Kumar Jha N., Thangavelu L., Kumar Chellappan D., Dua K. Molecular exploration of combinational therapy of orlistat with metformin prevents the COVID-19 consequences in obese diabetic patients. Eur. Rev. Med. Pharmacol. Sci. 2021;25:580&#x2013;582.</Citation><ArticleIdList><ArticleId IdType="pubmed">33577009</ArticleId></ArticleIdList></Reference><Reference><Citation>Crisan-Dabija R., Grigorescu C., Pavel C.A., Artene B., Popa I.V., Cernomaz A., Burlacu A. Tuberculosis and COVID-19: lessons from the past viral outbreaks and possible future outcomes. Cancer Res. J. 2020;2020:1401053.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7479474</ArticleId><ArticleId IdType="pubmed">32934758</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouazza B., Hadj-Said D., Pescatore K.A., Chahed R. Are patients with asthma and chronic obstructive pulmonary disease preferred targets of COVID-19? Tuberc. Respir. Dis. 2021;84:22&#x2013;34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7801803</ArticleId><ArticleId IdType="pubmed">33099990</ArticleId></ArticleIdList></Reference><Reference><Citation>Phua J., Weng L., Ling L., Egi M., Lim C.-M., Divatia J.V., Shrestha B.R., Arabi Y.M., Ng J., Gomersall C.D., Nishimura M., Koh Y., Du B. Intensive care management of coronavirus disease 2019 (COVID-19): challenges and recommendations. Lancet Respir. Med. 2020;8:506&#x2013;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7198848</ArticleId><ArticleId IdType="pubmed">32272080</ArticleId></ArticleIdList></Reference><Reference><Citation>R. Laxminarayan, C.M. B, V.T. G, K.V. Arjun Kumar, B. Wahl, J.A. Lewnard, SARS-CoV-2 infection and mortality during the first epidemic wave in Madurai, south India: a prospective, active surveillance study, Lancet Infect. Dis..</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8363227</ArticleId><ArticleId IdType="pubmed">34399090</ArticleId></ArticleIdList></Reference><Reference><Citation>Morens D.M., Fauci A.S. The 1918 influenza pandemic: insights for the 21st century. J. Infect. Dis. 2007;195:1018&#x2013;1028.</Citation><ArticleIdList><ArticleId IdType="pubmed">17330793</ArticleId></ArticleIdList></Reference><Reference><Citation>Shieh W.J., Blau D.M., Denison A.M., Deleon-Carnes M., Adem P., Bhatnagar J., Sumner J., Liu L., Patel M., Batten B., Greer P., Jones T., Smith C., Bartlett J., Montague J., White E., Rollin D., Gao R., Seales C., Jost H., Metcalfe M., Goldsmith C.S., Humphrey C., Schmitz A., Drew C., Paddock C., Uyeki T.M., Zaki S.R. pandemic influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am. J. Pathol. 2009;177:166&#x2013;175. 2010.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2893660</ArticleId><ArticleId IdType="pubmed">20508031</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar D., Gupta G., Jhamb U. IDDF2019-ABS-0014 Gastrointestinal symptoms among hospitalized children admitted with h1n1 infection: a report from a tertiary hospital in north India. Gut. 2019;68 A61-A61.</Citation></Reference><Reference><Citation>Zhang D., Li S., Wang N., Tan H.Y., Zhang Z., Feng Y. The cross-talk between gut microbiota and lungs in common lung diseases. Front. Microbiol. 2020;11:301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7052046</ArticleId><ArticleId IdType="pubmed">32158441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar Gothwal S., Singh V.B., Shrivastava M., Banseria R., Goyal K., Singh S., Ali H., Saad Alharbi K., Singh Y., Gupta G. Complete blood-count-based inflammatory score (CBCS) of COVID-19 patients at tertiary care center. Alternative Ther. Health Med. 2021;27:18&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">33609349</ArticleId></ArticleIdList></Reference><Reference><Citation>G. Gupta, R. S., Y. Singh, L. Thangavelu, S.K. Singh, H. Dureja, D.K. Chellappan, K. Dua, Emerging Cases of Mucormycosis under COVID-19 Pandemic in India: Misuse of Antibiotics, Drug Dev Res., (n/a).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426670</ArticleId><ArticleId IdType="pubmed">34323298</ArticleId></ArticleIdList></Reference><Reference><Citation>Moore J.B., June C.H. Cytokine release syndrome in severe COVID-19. Science (New York, N.Y.) 2020;368:473&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pubmed">32303591</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh Y., Gupta G., Kazmi I., Al-Abbasi F.A., Negi P., Chellappan D.K., Dua K. SARS CoV-2 aggravates cellular metabolism mediated complications in COVID-19 infection. Dermatol. Ther. 2020;33</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7323108</ArticleId><ArticleId IdType="pubmed">32558055</ArticleId></ArticleIdList></Reference><Reference><Citation>Kernan K.F., Carcillo J.A. Hyperferritinemia and inflammation. Int. Immunol. 2017;29:401&#x2013;409.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5890889</ArticleId><ArticleId IdType="pubmed">28541437</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh Y., Fuloria N.K., Fuloria S., Subramaniyan V., Almalki W.H., Gupta G., Shaikh M.A.J., Singh M., Al-Abbasi F.A., Kazmi I. Drug Dev Res.; 2021. Disruption of the Biological Activity of Protease-Activated Receptors2/4 in Adults rather than Children in SARS CoV-2 Virus-Mediated Mortality in COVID-19 Infection.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8653207</ArticleId><ArticleId IdType="pubmed">34469011</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta G., Singh Y., Chellappan D., Dua K. Emerging dermatological symptoms in coronavirus pandemic. J. Cosmet. Dermatol. 2020;19:2447&#x2013;2448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7267585</ArticleId><ArticleId IdType="pubmed">32365277</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chen H., Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K.S., Hung I.F.N., Chan P.P.Y., Lung K.C., Tso E., Liu R., Ng Y.Y., Chu M.Y., Chung T.W.H., Tam A.R., Yip C.C.Y., Leung K.-H., Fung A.Y.-F., Zhang R.R., Lin Y., Cheng H.M., Zhang A.J.X., To K.K.W., Chan K.-H., Yuen K.-Y., Leung W.K. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159:81&#x2013;95.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7194936</ArticleId><ArticleId IdType="pubmed">32251668</ArticleId></ArticleIdList></Reference><Reference><Citation>Din A.U., Mazhar M., Waseem M., Ahmad W., Bibi A., Hassan A., Ali N., Gang W., Qian G., Ullah R., Shah T., Ullah M., Khan I., Nisar M.F., Wu J. SARS-CoV-2 microbiome dysbiosis linked disorders and possible probiotics role. Biomed. Pharmacother. 2021;133:110947.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7657099</ArticleId><ArticleId IdType="pubmed">33197765</ArticleId></ArticleIdList></Reference><Reference><Citation>Banseria R., Shrivastava M., Meena H., Kumar Gothwal S., Meratwal G., Singh V.B., Singh Y., Kazmi I., Al-Abbasi F.A., Almalki Z.S., Khan M.F. Altern Ther Health Med; 2021. Changes in Hematological Parameters by Quantifying HRCT Chest Results in Patients with COVID-19 in Tertiary Care Hospital.</Citation><ArticleIdList><ArticleId IdType="pubmed">34097650</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y., Zhang L., Fan G., Xu J., Gu X., Cheng Z., Yu T., Xia J., Wei Y., Wu W., Xie X., Yin W., Li H., Liu M., Xiao Y., Gao H., Guo L., Xie J., Wang G., Jiang R., Gao Z., Jin Q., Wang J., Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Rubin R. As their numbers grow, COVID-19 "long haulers" stump experts. JAMA. 2020;324:1381&#x2013;1383.</Citation><ArticleIdList><ArticleId IdType="pubmed">32965460</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A'Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Del Rio C., Malani P.N. COVID-19-New insights on a rapidly changing epidemic. JAMA. 2020;323:1339&#x2013;1340.</Citation><ArticleIdList><ArticleId IdType="pubmed">32108857</ArticleId></ArticleIdList></Reference><Reference><Citation>Greenhalgh T., Knight M., A'Court C., Buxton M., Husain L. Management of post-acute covid-19 in primary care. BMJ. 2020;370:m3026.</Citation><ArticleIdList><ArticleId IdType="pubmed">32784198</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259&#x2013;264.</Citation><ArticleIdList><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., Villapol S. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci. Rep. 2021;11:16144.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>India T.o. Time of India; India: Sep 10, 2021. Covishield Vaccine Side-Effects: 4 New Side-Effects Discovered with the Astrazeneca COVID Shot.</Citation></Reference><Reference><Citation>Salyers A.A. Bacteroides of the human lower intestinal tract. Annu. Rev. Microbiol. 1984;38:293&#x2013;313.</Citation><ArticleIdList><ArticleId IdType="pubmed">6388494</ArticleId></ArticleIdList></Reference><Reference><Citation>B&#xe4;ckhed F., Ley R.E., Sonnenburg J.L., Peterson D.A., Gordon J.I. Host-bacterial mutualism in the human intestine. Science (New York, N.Y.) 2005;307:1915&#x2013;1920.</Citation><ArticleIdList><ArticleId IdType="pubmed">15790844</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirmer M., Smeekens S.P., Vlamakis H., Jaeger M., Oosting M., Franzosa E.A., Ter Horst R., Jansen T., Jacobs L., Bonder M.J., Kurilshikov A., Fu J., Joosten L.A.B., Zhernakova A., Huttenhower C., Wijmenga C., Netea M.G., Xavier R.J. Linking the human gut microbiome to inflammatory cytokine production capacity. Cell. 2016;167:1125&#x2013;1136. e1128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5131922</ArticleId><ArticleId IdType="pubmed">27814509</ArticleId></ArticleIdList></Reference><Reference><Citation>Belkaid Y., Hand T.W. Role of the microbiota in immunity and inflammation. Cell. 2014;157:121&#x2013;141.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056765</ArticleId><ArticleId IdType="pubmed">24679531</ArticleId></ArticleIdList></Reference><Reference><Citation>Schirmer M., Kumar V., Netea M.G., Xavier R.J. The causes and consequences of variation in human cytokine production in health. Curr. Opin. Immunol. 2018;54:50&#x2013;58.</Citation><ArticleIdList><ArticleId IdType="pubmed">29913309</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xe1;nchez E., Laparra J.M., Sanz Y. Discerning the role of Bacteroides fragilis in celiac disease pathogenesis. Appl. Environ. Microbiol. 2012;78:6507&#x2013;6515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3426693</ArticleId><ArticleId IdType="pubmed">22773639</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooper L.V., Midtvedt T., Gordon J.I. How host-microbial interactions shape the nutrient environment of the mammalian intestine. Annu. Rev. Nutr. 2002;22:283&#x2013;307.</Citation><ArticleIdList><ArticleId IdType="pubmed">12055347</ArticleId></ArticleIdList></Reference><Reference><Citation>Wexler H.M. Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 2007;20:593&#x2013;621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2176045</ArticleId><ArticleId IdType="pubmed">17934076</ArticleId></ArticleIdList></Reference><Reference><Citation>Crouch L.I., Liberato M.V., Urbanowicz P.A., Basl&#xe9; A., Lamb C.A., Stewart C.J., Cooke K., Doona M., Needham S., Brady R.R., Berrington J.E., Madunic K., Wuhrer M., Chater P., Pearson J.P., Glowacki R., Martens E.C., Zhang F., Linhardt R.J., Spencer D.I.R., Bolam D.N. Prominent members of the human gut microbiota express endo-acting O-glycanases to initiate mucin breakdown. Nat. Commun. 2020;11:4017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7419316</ArticleId><ArticleId IdType="pubmed">32782292</ArticleId></ArticleIdList></Reference><Reference><Citation>Eckburg P.B., Bik E.M., Bernstein C.N., Purdom E., Dethlefsen L., Sargent M., Gill S.R., Nelson K.E., Relman D.A. Diversity of the human intestinal microbial flora. Science (New York, N.Y.) 2005;308:1635&#x2013;1638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1395357</ArticleId><ArticleId IdType="pubmed">15831718</ArticleId></ArticleIdList></Reference><Reference><Citation>Brook I., Frazier E.H. Aerobic and anaerobic microbiology in intra-abdominal infections associated with diverticulitis. J. Med. Microbiol. 2000;49:827&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pubmed">10966232</ArticleId></ArticleIdList></Reference><Reference><Citation>S&#xf3;ki J., Gal M., Brazier J.S., Rotimi V.O., Urb&#xe1;n E., Nagy E., Duerden B.I. Molecular investigation of genetic elements contributing to metronidazole resistance in Bacteroides strains. J. Antimicrob. Chemother. 2006;57:212&#x2013;220.</Citation><ArticleIdList><ArticleId IdType="pubmed">16338949</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafar H., Saier M.H., Jr. Comparative genomics of transport proteins in seven Bacteroides species. PLoS One. 2018;13</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6281302</ArticleId><ArticleId IdType="pubmed">30517169</ArticleId></ArticleIdList></Reference><Reference><Citation>Stelter C., K&#xe4;ppeli R., K&#xf6;nig C., Krah A., Hardt W.D., Stecher B., Bumann D. Salmonella-induced mucosal lectin RegIII&#x3b2; kills competing gut microbiota. PLoS One. 2011;6</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3111430</ArticleId><ArticleId IdType="pubmed">21694778</ArticleId></ArticleIdList></Reference><Reference><Citation>Miki T., Okada N., Hardt W.-D. Inflammatory bactericidal lectin RegIII&#x3b2;: friend or foe for the host? Gut Microb. 2018;9:179&#x2013;187.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5989794</ArticleId><ArticleId IdType="pubmed">28985140</ArticleId></ArticleIdList></Reference><Reference><Citation>Diard M., Hardt W.D. Evolution of bacterial virulence. FEMS Microbiol. Rev. 2017;41:679&#x2013;697.</Citation><ArticleIdList><ArticleId IdType="pubmed">28531298</ArticleId></ArticleIdList></Reference><Reference><Citation>Miki T., Goto R., Fujimoto M., Okada N., Hardt W.D. The bactericidal lectin RegIII&#x3b2; prolongs gut colonization and enteropathy in the streptomycin mouse model for Salmonella diarrhea. Cell Host Microbe. 2017;21:195&#x2013;207.</Citation><ArticleIdList><ArticleId IdType="pubmed">28111202</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinohe T., Pang I.K., Kumamoto Y., Peaper D.R., Ho J.H., Murray T.S., Iwasaki A. Microbiota regulates immune defense against respiratory tract influenza A virus infection. Proc. Natl. Acad. Sci. U. S. A. 2011;108:5354&#x2013;5359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3069176</ArticleId><ArticleId IdType="pubmed">21402903</ArticleId></ArticleIdList></Reference><Reference><Citation>Ichinohe T., Lee H.K., Ogura Y., Flavell R., Iwasaki A. Inflammasome recognition of influenza virus is essential for adaptive immune responses. J. Exp. Med. 2009;206:79&#x2013;87.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2626661</ArticleId><ArticleId IdType="pubmed">19139171</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy E.A., King K.Y., Baldridge M.T. Mouse microbiota models: comparing germ-free mice and antibiotics treatment as tools for modifying gut bacteria. Front. Physiol. 2018;9:1534.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6220354</ArticleId><ArticleId IdType="pubmed">30429801</ArticleId></ArticleIdList></Reference><Reference><Citation>Pfeiffer J.K., Sonnenburg J.L. The intestinal microbiota and viral susceptibility. Front. Microbiol. 2011;2:92.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3153051</ArticleId><ArticleId IdType="pubmed">21833331</ArticleId></ArticleIdList></Reference><Reference><Citation>McCormick A.L., Mocarski E.S. In: Human Herpesviruses: Biology, Therapy, and Immunoprophylaxis. Arvin A., Roizman B., Mocarski E., Campadelli-Fiume G., Yamanishi K., Moore P.S., Whitley R., editors. Cambridge University Press; Cambridge: 2007. CMV modulation of the host response to infection; pp. 324&#x2013;338.</Citation><ArticleIdList><ArticleId IdType="pubmed">21348071</ArticleId></ArticleIdList></Reference><Reference><Citation>Zafar H., Saier M.H. Gut Bacteroides species in health and disease. Gut Microb. 2021;13:1848158.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7872030</ArticleId><ArticleId IdType="pubmed">33535896</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Li Q., Yin Y., Zhang Y., Cao Y., Lin X., Huang L., Hoffmann D., Lu M., Qiu Y. Excessive neutrophils and neutrophil extracellular traps in COVID-19. Front. Immunol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461898</ArticleId><ArticleId IdType="pubmed">33013872</ArticleId></ArticleIdList></Reference><Reference><Citation>Reusch N., De Domenico E., Bonaguro L., Schulte-Schrepping J., Ba&#xdf;ler K., Schultze J.L., Aschenbrenner A.C. Neutrophils in COVID-19. Front. Immunol. 2021;12</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8027077</ArticleId><ArticleId IdType="pubmed">33841435</ArticleId></ArticleIdList></Reference><Reference><Citation>Catanzaro M., Fagiani F., Racchi M., Corsini E., Govoni S., Lanni C. Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct. Targeted Therapy. 2020;5:84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255975</ArticleId><ArticleId IdType="pubmed">32467561</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C., Huang Y., Shi F., Tan K., Ma Q., Chen Y., Jiang X., Li X. C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early. J. Med. Virol. 2020;92:856&#x2013;862.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262341</ArticleId><ArticleId IdType="pubmed">32281668</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh Y., Fuloria N.K., Fuloria S., Subramaniyan V., Meenakshi D.U., Chakravarthi S., Kumari U., Joshi N., Gupta G. N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals. J. Med. Virol. 2021;93:5726&#x2013;5728.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8426848</ArticleId><ArticleId IdType="pubmed">34232521</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh Y., Gupta G., Satija S., Pabreja K., Chellappan D.K., Dua K. COVID-19 transmission through host cell directed network of GPCR. Drug Dev. Res. 2020;81:647&#x2013;649.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264679</ArticleId><ArticleId IdType="pubmed">32329083</ArticleId></ArticleIdList></Reference><Reference><Citation>Gustine J.N., Jones D. Immunopathology of hyperinflammation in COVID-19. Am. J. Pathol. 2021;191:4&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7484812</ArticleId><ArticleId IdType="pubmed">32919977</ArticleId></ArticleIdList></Reference><Reference><Citation>Amraei R., Yin W., Napoleon M.A., Suder E.L., Berrigan J., Zhao Q., Olejnik J., Chandler K.B., Xia C., Feldman J., Hauser B.M., Caradonna T.M., Schmidt A.G., Gummuluru S., Muhlberger E., Chitalia V., Costello C.E., Rahimi N. 2021. CD209L/L-SIGN and CD209/DC-SIGN Act as Receptors for SARS-CoV-2, bioRxiv : the Preprint Server for Biology.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8265543</ArticleId><ArticleId IdType="pubmed">34341769</ArticleId></ArticleIdList></Reference><Reference><Citation>Soh W.T., Liu Y., Nakayama E.E., Ono C., Torii S., Nakagami H., Matsuura Y., Shioda T., Arase H. 2020. The N-Terminal Domain of Spike Glycoprotein Mediates SARS-CoV-2 Infection by Associating with L-SIGN and DC-SIGN, bioRxiv : the Preprint Server for Biology. 2020.2011.2005.369264.</Citation></Reference><Reference><Citation>Wang K., Chen W., Zhang Z., Deng Y., Lian J.Q., Du P., Wei D., Zhang Y., Sun X.X., Gong L., Yang X., He L., Zhang L., Yang Z., Geng J.J., Chen R., Zhang H., Wang B., Zhu Y.M., Nan G., Jiang J.L., Li L., Wu J., Lin P., Huang W., Xie L., Zheng Z.H., Zhang K., Miao J.L., Cui H.Y., Huang M., Zhang J., Fu L., Yang X.M., Zhao Z., Sun S., Gu H., Wang Z., Wang C.F., Lu Y., Liu Y.Y., Wang Q.Y., Bian H., Zhu P., Chen Z.N. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells. Signal Transduct Target Ther. 2020;5:283.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7714896</ArticleId><ArticleId IdType="pubmed">33277466</ArticleId></ArticleIdList></Reference><Reference><Citation>Cantuti-Castelvetri L., Ojha R., Pedro L.D., Djannatian M., Franz J., Kuivanen S., van der Meer F., Kallio K., Kaya T., Anastasina M., Smura T., Levanov L., Szirovicza L., Tobi A., Kallio-Kokko H., &#xd6;sterlund P., Joensuu M., Meunier F.A., Butcher S.J., Winkler M.S., Mollenhauer B., Helenius A., Gokce O., Teesalu T., Hepojoki J., Vapalahti O., Stadelmann C., Balistreri G., Simons M. Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity. Science (New York, N.Y.) 2020;370:856&#x2013;860.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7857391</ArticleId><ArticleId IdType="pubmed">33082293</ArticleId></ArticleIdList></Reference><Reference><Citation>Clausen T.M., Sandoval D.R., Spliid C.B., Pihl J., Perrett H.R., Painter C.D., Narayanan A., Majowicz S.A., Kwong E.M., McVicar R.N., Thacker B.E., Glass C.A., Yang Z., Torres J.L., Golden G.J., Bartels P.L., Porell R.N., Garretson A.F., Laubach L., Feldman J., Yin X., Pu Y., Hauser B.M., Caradonna T.M., Kellman B.P., Martino C., Gordts P.L.S.M., Chanda S.K., Schmidt A.G., Godula K., Leibel S.L., Jose J., Corbett K.D., Ward A.B., Carlin A.F., Esko J.D. SARS-CoV-2 infection depends on cellular heparan sulfate and ACE2. Cell. 2020;183:1043&#x2013;1057. e1015.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7489987</ArticleId><ArticleId IdType="pubmed">32970989</ArticleId></ArticleIdList></Reference><Reference><Citation>Lempp F.A., Soriaga L., Montiel-Ruiz M., Benigni F., Noack J., Park Y.-J., Bianchi S., Walls A.C., Bowen J.E., Zhou J., Kaiser H., Joshi A., Agostini M., Meury M., Dellota E., Jaconi S., Cameroni E., Martinez-Picado J., Vergara-Alert J., Izquierdo-Useros N., Virgin H.W., Lanzavecchia A., Veesler D., Purcell L., Telenti A., Corti D. Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies. Nature. 2021</Citation><ArticleIdList><ArticleId IdType="pubmed">34464958</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., Tavera-Mendoza L., Lin R., Hanrahan J.W., Mader S., White J.H. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. J. Immunol. 2004;173:2909&#x2013;2912.</Citation><ArticleIdList><ArticleId IdType="pubmed">15322146</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan H., Liang X., Du J., He Z., Wang Y., Lyu M., Yue L., Zhang F., Xue Z., Xu L., Ruan G., Li J., Zhu H., Xu J., Chen S., Zhang C., Lv D., Lin Z., Shen B., Zhu Y., Qian B., Chen H., Guo T. medRxiv; 2021. Proteomic and Metabolomic Investigation of COVID-19 Patients with Elevated Serum Lactate Dehydrogenase. 2021.2001.2010.21249333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8237019</ArticleId><ArticleId IdType="pubmed">33987944</ArticleId></ArticleIdList></Reference><Reference><Citation>AbdelMassih A.F., Kamel A., Mishriky F., Ismail H.-A., El Qadi L., Malak L., El-Husseiny M., Ashraf M., Hafez N., AlShehry N., El-Husseiny N., AbdelRaouf N., Shebl N., Hafez N., Youssef N., Afdal P., Hozaien R., Menshawey R., Saeed R., Fouda R. Is it infection or rather vascular inflammation? Game-changer insights and recommendations from patterns of multi-organ involvement and affected subgroups in COVID-19. Cardiovasc. Endocrinol. Metabol. 2020;9:110&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7410022</ArticleId><ArticleId IdType="pubmed">32803145</ArticleId></ArticleIdList></Reference><Reference><Citation>Magro B., Zuccaro V., Novelli L., Zileri L., Celsa C., Raimondi F., Gori M., Camm&#xe0; G., Battaglia S., Genova V.G., Paris L., Tacelli M., Mancarella F.A., Enea M., Attanasio M., Senni M., Di Marco F., Lorini L.F., Fagiuoli S., Bruno R., Camm&#xe0; C., Gasbarrini A. Predicting in-hospital mortality from Coronavirus Disease 2019: a simple validated app for clinical use. PLoS One. 2021;16</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7808616</ArticleId><ArticleId IdType="pubmed">33444411</ArticleId></ArticleIdList></Reference><Reference><Citation>Terpos E., Ntanasis-Stathopoulos I., Elalamy I., Kastritis E., Sergentanis T.N., Politou M., Psaltopoulou T., Gerotziafas G., Dimopoulos M.A. Hematological findings and complications of COVID-19. Am. J. Hematol. 2020;95:834&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7262337</ArticleId><ArticleId IdType="pubmed">32282949</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N., Li D., Wang X., Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J. Thromb. Haemostasis. 2020;18:844&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Cummings M.J., Baldwin M.R., Abrams D., Jacobson S.D., Meyer B.J., Balough E.M., Aaron J.G., Claassen J., Rabbani L.E., Hastie J., Hochman B.R., Salazar-Schicchi J., Yip N.H., Brodie D., O'Donnell M.R. Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. Lancet. 2020;395:1763&#x2013;1770.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237188</ArticleId><ArticleId IdType="pubmed">32442528</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P., McAuley D.F., Brown M., Sanchez E., Tattersall R.S., Manson J.J. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033&#x2013;1034.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang H., Cai S., Li Y., Li Y., Fan Y., Li L., Lei C., Tang X., Hu F., Li F., Deng X. Prognostic factors for COVID-19 pneumonia progression to severe symptoms based on earlier clinical features: a retrospective analysis. Front. Med. 2020;7</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7571455</ArticleId><ArticleId IdType="pubmed">33123541</ArticleId></ArticleIdList></Reference><Reference><Citation>Schalekamp S., Huisman M., Dijk R.A.v., Boomsma M.F., Jorge P.J.F., Boer W.S.d., Herder G.J.M., Bonarius M., Groot O.A., Jong E., Schreuder A., Schaefer-Prokop C.M. Model-based prediction of critical illness in hospitalized patients with COVID-19. Radiology. 2021;298:E46&#x2013;E54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7427120</ArticleId><ArticleId IdType="pubmed">32787701</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang I., Pranata R., Lim M.A., Oehadian A., Alisjahbana B. C-reactive protein, procalcitonin, D-dimer, and ferritin in severe coronavirus disease-2019: a meta-analysis. Ther. Adv. Respir. Dis. 2020;14 1753466620937175.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7336828</ArticleId><ArticleId IdType="pubmed">32615866</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chen H., Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054&#x2013;1062.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Lim M.A., Pranata R., Huang I., Yonas E., Soeroto A.Y., Supriyadi R. Multiorgan failure with emphasis on acute kidney injury and severity of COVID-19: systematic review and meta-analysis. Can. J. Kidney Health Dis. 2020;7 2054358120938573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7343353</ArticleId><ArticleId IdType="pubmed">32685180</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan L., Zhang H.-T., Goncalves J., Xiao Y., Wang M., Guo Y., Sun C., Tang X., Jing L., Zhang M., Huang X., Xiao Y., Cao H., Chen Y., Ren T., Wang F., Xiao Y., Huang S., Tan X., Huang N., Jiao B., Cheng C., Zhang Y., Luo A., Mombaerts L., Jin J., Cao Z., Li S., Xu H., Yuan Y. An interpretable mortality prediction model for COVID-19 patients. Nat. Mach. Intell. 2020;2(2):283&#x2013;288.</Citation></Reference><Reference><Citation>Szarpak L., Ruetzler K., Safiejko K., Hampel M., Pruc M., Kanczuga-Koda L., Filipiak K.J., Jaguszewski M.J. Lactate dehydrogenase level as a COVID-19 severity marker. Am. J. Emerg. Med. 2021;45:638&#x2013;639.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7666711</ArticleId><ArticleId IdType="pubmed">33246860</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu J., Wei Z., Jiang H., Cheng L., Chen Q., Chen M., Yan J., Sun Z. Lactate dehydrogenase is associated with 28-day mortality in patients with sepsis: a retrospective observational study. J. Surg. Res. 2018;228:314&#x2013;321.</Citation><ArticleIdList><ArticleId IdType="pubmed">29907227</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L. C-reactive protein levels in the early stage of COVID-19. Med. Maladies Infect. 2020;50:332&#x2013;334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7146693</ArticleId><ArticleId IdType="pubmed">32243911</ArticleId></ArticleIdList></Reference><Reference><Citation>Peng Y.D., Meng K., Guan H.Q., Leng L., Zhu R.R., Wang B.Y., He M.A., Cheng L.X., Huang K., Zeng Q.T. [Clinical characteristics and outcomes of 112 cardiovascular disease patients infected by 2019-nCoV] Zhonghua Xinxueguanbing Zazhi. 2020;48:450&#x2013;455.</Citation><ArticleIdList><ArticleId IdType="pubmed">32120458</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Wu D., Guo W., Cao Y., Huang D., Wang H., Wang T., Zhang X., Chen H., Yu H., Zhang X., Zhang M., Wu S., Song J., Chen T., Han M., Li S., Luo X., Zhao J., Ning Q. Clinical and immunological features of severe and moderate coronavirus disease 2019. J. Clin. Invest. 2020;130:2620&#x2013;2629.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7190990</ArticleId><ArticleId IdType="pubmed">32217835</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichtenauer M., Wernly B., Ohnewein B., Franz M., Kabisch B., Muessig J., Masyuk M., Lauten A., Schulze P.C., Hoppe U.C., Kelm M., Jung C. The lactate/albumin ratio: a valuable tool for risk stratification in septic patients admitted to ICU. Int. J. Mol. Sci. 2017;18:1893.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5618542</ArticleId><ArticleId IdType="pubmed">28869492</ArticleId></ArticleIdList></Reference><Reference><Citation>Booth A.L., Abels E., McCaffrey P. Development of a prognostic model for mortality in COVID-19 infection using machine learning. Mod. Pathol. 2021;34:522&#x2013;531.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7567420</ArticleId><ArticleId IdType="pubmed">33067522</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcoran S.E., O'Neill L.A. HIF1&#x3b1; and metabolic reprogramming in inflammation. J. Clin. Invest. 2016;126:3699&#x2013;3707.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5096812</ArticleId><ArticleId IdType="pubmed">27571407</ArticleId></ArticleIdList></Reference><Reference><Citation>Douglas J.J., Walley K.R. Metabolic changes in cardiomyocytes during sepsis. Crit. Care. 2013;17:186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4056895</ArticleId><ArticleId IdType="pubmed">24053782</ArticleId></ArticleIdList></Reference><Reference><Citation>Kitsios G.D., Yang H., Yang L., Qin S., Fitch A., Wang X.H., Fair K., Evankovich J., Bain W., Shah F., Li K., Meth&#xe9; B., Benos P.V., Morris A., McVerry B.J. Respiratory tract dysbiosis is associated with worse outcomes in mechanically ventilated patients. Am. J. Respir. Crit. Care Med. 2020;202:1666&#x2013;1677.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737572</ArticleId><ArticleId IdType="pubmed">32717152</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson R.P., Singer B.H., Newstead M.W., Falkowski N.R., Erb-Downward J.R., Standiford T.J., Huffnagle G.B. Enrichment of the lung microbiome with gut bacteria in sepsis and the acute respiratory distress syndrome. Nat. Microbiol. 2016;1:16113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5076472</ArticleId><ArticleId IdType="pubmed">27670109</ArticleId></ArticleIdList></Reference><Reference><Citation>Dickson R.P., Schultz M.J., van der Poll T., Schouten L.R., Falkowski N.R., Luth J.E., Sjoding M.W., Brown C.A., Chanderraj R., Huffnagle G.B., Bos L.D.J. Lung microbiota predict clinical outcomes in critically ill patients. Am. J. Respir. Crit. Care Med. 2020;201:555&#x2013;563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7047465</ArticleId><ArticleId IdType="pubmed">31973575</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X., Liao B., Cheng L., Peng X., Xu X., Li Y., Hu T., Li J., Zhou X., Ren B. The microbial coinfection in COVID-19. Appl. Microbiol. Biotechnol. 2020;104:7777&#x2013;7785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7417782</ArticleId><ArticleId IdType="pubmed">32780290</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhang F., Lui G.C.Y., Yeoh Y.K., Li A.Y.L., Zhan H., Wan Y., Chung A.C.K., Cheung C.P., Chen N., Lai C.K.C., Chen Z., Tso E.Y.K., Fung K.S.C., Chan V., Ling L., Joynt G., Hui D.S.C., Chan F.K.L., Chan P.K.S., Ng S.C. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159:944&#x2013;955. e948.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237927</ArticleId><ArticleId IdType="pubmed">32442562</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferreira C., Viana S.D., Reis F. Gut microbiota dysbiosis-immune hyperresponse-inflammation triad in coronavirus disease 2019 (COVID-19): impact of pharmacological and nutraceutical approaches. Microorganisms. 2020;8:1514.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7601735</ArticleId><ArticleId IdType="pubmed">33019592</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu S., Chen Y., Wu Z., Chen Y., Gao H., Lv L., Guo F., Zhang X., Luo R., Huang C., Lu H., Zheng B., Zhang J., Yan R., Zhang H., Jiang H., Xu Q., Guo J., Gong Y., Tang L., Li L. Alterations of the gut microbiota in patients with coronavirus disease 2019 or H1N1 influenza. Clin. Infect. Dis. 2020;71:2669&#x2013;2678.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7314193</ArticleId><ArticleId IdType="pubmed">32497191</ArticleId></ArticleIdList></Reference><Reference><Citation>Zuo T., Zhan H., Zhang F., Liu Q., Tso E.Y.K., Lui G.C.Y., Chen N., Li A., Lu W., Chan F.K.L., Chan P.K.S., Ng S.C. Alterations in fecal fungal microbiome of patients with COVID-19 during time of hospitalization until discharge. Gastroenterology. 2020;159:1302&#x2013;1310. e1305.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7318920</ArticleId><ArticleId IdType="pubmed">32598884</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao W., Zhang G., Wang X., Guo M., Zeng W., Xu Z., Cao D., Pan A., Wang Y., Zhang K., Ma X., Chen Z., Jin T., Liu L., Weng J., Zhu S. Analysis of the intestinal microbiota in COVID-19 patients and its correlation with the inflammatory factor IL-18. Med. Microecol. 2020;5:100023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7832617</ArticleId><ArticleId IdType="pubmed">34173452</ArticleId></ArticleIdList></Reference><Reference><Citation>Forrester J.D., Spain D.A. Clostridium ramosum bacteremia: case report and literature review. Surg. Infect. 2014;15:343&#x2013;346.</Citation><ArticleIdList><ArticleId IdType="pubmed">24283763</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang T., Chakraborty S., Saha P., Mell B., Cheng X., Yeo J.Y., Mei X., Zhou G., Mandal J., Golonka R., Yeoh B.S., Putluri V., Piyarathna D.W.B., Putluri N., McCarthy C.G., Wenceslau C.F., Sreekumar A., Gewirtz A.T., Vijay-Kumar M., Joe B. Gnotobiotic rats reveal that gut microbiota regulates colonic mRNA of Ace2, the receptor for SARS-CoV-2 infectivity. Hypertension. 2020;76:e1&#x2013;e3. Dallas, Tex. : 1979.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7379164</ArticleId><ArticleId IdType="pubmed">32426999</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsayed S., Zhang K. Human infection caused by Clostridium hathewayi. Emerg. Infect. Dis. 2004;10:1950&#x2013;1952.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3328985</ArticleId><ArticleId IdType="pubmed">15550205</ArticleId></ArticleIdList></Reference><Reference><Citation>Geva-Zatorsky N., Sefik E., Kua L., Pasman L., Tan T.G., Ortiz-Lopez A., Yanortsang T.B., Yang L., Jupp R., Mathis D., Benoist C., Kasper D.L. Mining the human gut microbiota for immunomodulatory organisms. Cell. 2017;168:928&#x2013;943. e911.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7774263</ArticleId><ArticleId IdType="pubmed">28215708</ArticleId></ArticleIdList></Reference><Reference><Citation>Hill M.A., Mantzoros C., Sowers J.R. Commentary: COVID-19 in patients with diabetes. Metabolism. 2020;107 154217-154217.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102643</ArticleId><ArticleId IdType="pubmed">32220611</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang L., Karakiulakis G., Roth M. Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection? Lancet Respir. Med. 2020;8:e21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7118626</ArticleId><ArticleId IdType="pubmed">32171062</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai Q., Chen F., Wang T., Luo F., Liu X., Wu Q., He Q., Wang Z., Liu Y., Liu L., Chen J., Xu L. Obesity and COVID-19 severity in a designated hospital in shenzhen, China. Diabetes Care. 2020;43:1392&#x2013;1398.</Citation><ArticleIdList><ArticleId IdType="pubmed">32409502</ArticleId></ArticleIdList></Reference><Reference><Citation>Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027&#x2013;1031.</Citation><ArticleIdList><ArticleId IdType="pubmed">17183312</ArticleId></ArticleIdList></Reference><Reference><Citation>Emoto T., Yamashita T., Sasaki N., Hirota Y., Hayashi T., So A., Kasahara K., Yodoi K., Matsumoto T., Mizoguchi T., Ogawa W., Hirata K.-i. J Atheroscler Thromb.; advpub: 2016. Analysis of Gut Microbiota in Coronary Artery Disease Patients: a Possible Link between Gut Microbiota and Coronary Artery Disease.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7399299</ArticleId><ArticleId IdType="pubmed">26947598</ArticleId></ArticleIdList></Reference><Reference><Citation>Walmsley S.R., Print C., Farahi N., Peyssonnaux C., Johnson R.S., Cramer T., Sobolewski A., Condliffe A.M., Cowburn A.S., Johnson N., Chilvers E.R. Hypoxia-induced neutrophil survival is mediated by HIF-1&#x3b1;&#x2013;dependent NF-&#x3ba;B activity. J. Exp. Med. 2005;201:105&#x2013;115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2212759</ArticleId><ArticleId IdType="pubmed">15630139</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q., Liang X., Wang K., Lin J., Wang X., Wang P., Zhang Y., Nie Q., Liu H., Zhang Z., Liu J., Pang Y., Jiang C. Cell Metab; 2021. Intestinal Hypoxia-Inducible Factor 2&#x3b1; Regulates Lactate Levels to Shape the Gut Microbiome and Alter Thermogenesis.</Citation><ArticleIdList><ArticleId IdType="pubmed">34329568</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee D.C., Sohn H.A., Park Z.Y., Oh S., Kang Y.K., Lee K.M., Kang M., Jang Y.J., Yang S.J., Hong Y.K., Noh H., Kim J.A., Kim D.J., Bae K.H., Kim D.M., Chung S.J., Yoo H.S., Yu D.Y., Park K.C., Yeom Y.I. A lactate-induced response to hypoxia. Cell. 2015;161:595&#x2013;609.</Citation><ArticleIdList><ArticleId IdType="pubmed">25892225</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng M.Y., Inohara N., Nu&#xf1;ez G. Mechanisms of inflammation-driven bacterial dysbiosis in the gut. Mucosal Immunol. 2017;10:18&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5788567</ArticleId><ArticleId IdType="pubmed">27554295</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucke K., Miehlke S., Jacobs E., Schuppler M. Prevalence of Bacteroides and Prevotella spp. in ulcerative colitis. J. Med. Microbiol. 2006;55:617&#x2013;624.</Citation><ArticleIdList><ArticleId IdType="pubmed">16585651</ArticleId></ArticleIdList></Reference><Reference><Citation>Prindiville T.P., Sheikh R.A., Cohen S.H., Tang Y.J., Cantrell M.C., Silva J., Jr. Bacteroides fragilis enterotoxin gene sequences in patients with inflammatory bowel disease. Emerg. Infect. Dis. 2000;6:171&#x2013;174.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2640860</ArticleId><ArticleId IdType="pubmed">10756151</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas L&#xf3;pez R., Grande Burgos M.J., G&#xe1;lvez A., P&#xe9;rez Pulido R. The human gastrointestinal tract and oral microbiota in inflammatory bowel disease: a state of the science review. Apmis. 2017;125:3&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">27704622</ArticleId></ArticleIdList></Reference><Reference><Citation>Fei N., Zhao L. An opportunistic pathogen isolated from the gut of an obese human causes obesity in germfree mice. ISME J. 2013;7:880&#x2013;884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3603399</ArticleId><ArticleId IdType="pubmed">23235292</ArticleId></ArticleIdList></Reference><Reference><Citation>Brentani R.R. Biological implications of complementary hydropathy of amino acids. J. Theor. Biol. 1988;135:495&#x2013;499.</Citation><ArticleIdList><ArticleId IdType="pubmed">3256734</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith P.M., Howitt M.R., Panikov N., Michaud M., Gallini C.A., Bohlooly Y.M., Glickman J.N., Garrett W.S. The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis. Science (New York, N.Y.) 2013;341:569&#x2013;573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3807819</ArticleId><ArticleId IdType="pubmed">23828891</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirota K., Turner J.E., Villa M., Duarte J.H., Demengeot J., Steinmetz O.M., Stockinger B. Plasticity of Th17 cells in Peyer's patches is responsible for the induction of T cell-dependent IgA responses. Nat. Immunol. 2013;14:372&#x2013;379.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3672955</ArticleId><ArticleId IdType="pubmed">23475182</ArticleId></ArticleIdList></Reference><Reference><Citation>Macpherson A.J., Gatto D., Sainsbury E., Harriman G.R., Hengartner H., Zinkernagel R.M. A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria. Science (New York, N.Y.) 2000;288:2222&#x2013;2226.</Citation><ArticleIdList><ArticleId IdType="pubmed">10864873</ArticleId></ArticleIdList></Reference><Reference><Citation>Macpherson A.J., Uhr T. Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria. Science (New York, N.Y.) 2004;303:1662&#x2013;1665.</Citation><ArticleIdList><ArticleId IdType="pubmed">15016999</ArticleId></ArticleIdList></Reference><Reference><Citation>Peterson D.A., McNulty N.P., Guruge J.L., Gordon J.I. IgA response to symbiotic bacteria as a mediator of gut homeostasis. Cell Host Microbe. 2007;2:328&#x2013;339.</Citation><ArticleIdList><ArticleId IdType="pubmed">18005754</ArticleId></ArticleIdList></Reference><Reference><Citation>Hapfelmeier S., Lawson M.A., Slack E., Kirundi J.K., Stoel M., Heikenwalder M., Cahenzli J., Velykoredko Y., Balmer M.L., Endt K., Geuking M.B., Curtiss R., 3rd, McCoy K.D., Macpherson A.J. Reversible microbial colonization of germ-free mice reveals the dynamics of IgA immune responses. Science (New York, N.Y.) 2010;328:1705&#x2013;1709.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3923373</ArticleId><ArticleId IdType="pubmed">20576892</ArticleId></ArticleIdList></Reference><Reference><Citation>Popkin B.M., Du S., Green W.D., Beck M.A., Algaith T., Herbst C.H., Alsukait R.F., Alluhidan M., Alazemi N., Shekar M. Individuals with obesity and COVID-19: a global perspective on the epidemiology and biological relationships. Obes. Rev. 2020;21:e13128.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7461480</ArticleId><ArticleId IdType="pubmed">32845580</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreira-Ros&#xe1;rio A., Marques C., Pinheiro H., Ara&#xfa;jo J.R., Ribeiro P., Rocha R., Mota I., Pestana D., Ribeiro R., Pereira A., de Sousa M.J., Pereira-Leal J., de Sousa J., Morais J., Teixeira D., Rocha J.C., Silvestre M., Pr&#xed;ncipe N., Gatta N., Amado J., Santos L., Maltez F., Boquinhas A., de Sousa G., Germano N., Sarmento G., Granja C., P&#xf3;voa P., Faria A., Calhau C. 2021. Gut Microbiota Diversity and C-Reactive Protein Are Predictors of Disease Severity in COVID-19 Patients, bioRxiv : the Preprint Server for Biology. 2021.2004.2020.440658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8326578</ArticleId><ArticleId IdType="pubmed">34349747</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y., Shi X., Fu W., Xiang F., He X., Yang B., Wang X., Ma W.L. Gut microbiota dysbiosis correlates with abnormal immune response in moderate COVID-19 patients with fever. J. Inflamm. Res. 2021;14:2619&#x2013;2631.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8217908</ArticleId><ArticleId IdType="pubmed">34168484</ArticleId></ArticleIdList></Reference><Reference><Citation>Jackson S.A., Schoeni J.L., Vegge C., Pane M., Stahl B., Bradley M., Goldman V.S., Burgui&#xe8;re P., Atwater J.B., Sanders M.E. Improving end-user trust in the quality of commercial probiotic products. Front. Microbiol. 2019;10</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6499161</ArticleId><ArticleId IdType="pubmed">31105649</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin-Lee B., Curry W.J., Fetterman J., Graybill M.A., Karpa K. Patient experience and use of probiotics in community-based health care settings. Patient Prefer. Adherence. 2014;8:1513&#x2013;1520.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4222242</ArticleId><ArticleId IdType="pubmed">25382972</ArticleId></ArticleIdList></Reference><Reference><Citation>Mano M.C.R., Neri-Numa I.A., da Silva J.B., Paulino B.N., Pessoa M.G., Pastore G.M. Oligosaccharide biotechnology: an approach of prebiotic revolution on the industry. Appl. Microbiol. Biotechnol. 2018;102:17&#x2013;37.</Citation><ArticleIdList><ArticleId IdType="pubmed">29032473</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleerebezem M., Binda S., Bron P.A., Gross G., Hill C., van Hylckama Vlieg J.E.T., Lebeer S., Satokari R., Ouwehand A.C. Understanding mode of action can drive the translational pipeline towards more reliable health benefits for probiotics. Curr. Opin. Biotechnol. 2019;56:55&#x2013;60.</Citation><ArticleIdList><ArticleId IdType="pubmed">30296737</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaza-Diaz J., Ruiz-Ojeda F.J., Gil-Campos M., Gil A. Mechanisms of action of probiotics. Adv. Nutr. 2019;10:S49&#x2013;S66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6363529</ArticleId><ArticleId IdType="pubmed">30721959</ArticleId></ArticleIdList></Reference><Reference><Citation>Monteagudo-Mera A., Rastall R.A., Gibson G.R., Charalampopoulos D., Chatzifragkou A. Adhesion mechanisms mediated by probiotics and prebiotics and their potential impact on human health. Appl. Microbiol. Biotechnol. 2019;103:6463&#x2013;6472.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6667406</ArticleId><ArticleId IdType="pubmed">31267231</ArticleId></ArticleIdList></Reference><Reference><Citation>Lebeer S., Bron P.A., Marco M.L., Van Pijkeren J.P., O'Connell Motherway M., Hill C., Pot B., Roos S., Klaenhammer T. Identification of probiotic effector molecules: present state and future perspectives. Curr. Opin. Biotechnol. 2018;49:217&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pubmed">29153882</ArticleId></ArticleIdList></Reference><Reference><Citation>Plaza-Diaz J., Ruiz-Ojeda F.J., Gil-Campos M., Gil A. Mechanisms of action of probiotics. Adv. Nutr. 2019;10:S49&#x2013;S66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6363529</ArticleId><ArticleId IdType="pubmed">30721959</ArticleId></ArticleIdList></Reference><Reference><Citation>Biliavska L., Pankivska Y., Povnitsa O., Zagorodnya S. Antiviral activity of exopolysaccharides produced by lactic acid bacteria of the genera pediococcus, leuconostoc and Lactobacillus against human adenovirus type 5. Medicina (Kaunas) 2019;55:519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6780409</ArticleId><ArticleId IdType="pubmed">31443536</ArticleId></ArticleIdList></Reference><Reference><Citation>Mousavi E., Makvandi M., Teimoori A., Ataei A., Ghafari S., Samarbaf-Zadeh A. Antiviral effects of Lactobacillus crispatus against HSV-2 in mammalian cell lines. J. Chin. Med. Assoc. 2018;81:262&#x2013;267.</Citation><ArticleIdList><ArticleId IdType="pubmed">29037754</ArticleId></ArticleIdList></Reference><Reference><Citation>Villena J., Vizoso-Pinto M.G., Kitazawa H. Intestinal innate antiviral immunity and immunobiotics: beneficial effects against rotavirus infection. Front. Immunol. 2016;7:563.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5136547</ArticleId><ArticleId IdType="pubmed">27994593</ArticleId></ArticleIdList></Reference><Reference><Citation>Arena M.P., Capozzi V., Russo P., Drider D., Spano G., Fiocco D. Immunobiosis and probiosis: antimicrobial activity of lactic acid bacteria with a focus on their antiviral and antifungal properties. Appl. Microbiol. Biotechnol. 2018;102:9949&#x2013;9958.</Citation><ArticleIdList><ArticleId IdType="pubmed">30280241</ArticleId></ArticleIdList></Reference><Reference><Citation>Zelaya H., Tada A., Vizoso-Pinto M.G., Salva S., Kanmani P., Ag&#xfc;ero G., Alvarez S., Kitazawa H., Villena J. Nasal priming with immunobiotic Lactobacillus rhamnosus modulates inflammation&#x2013;coagulation interactions and reduces influenza virus-associated pulmonary damage. Inflamm. Res. 2015;64:589&#x2013;602.</Citation><ArticleIdList><ArticleId IdType="pubmed">26072063</ArticleId></ArticleIdList></Reference><Reference><Citation>Eguchi K., Fujitani N., Nakagawa H., Miyazaki T. Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055. Sci. Rep. 2019;9:4812.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6423325</ArticleId><ArticleId IdType="pubmed">30886158</ArticleId></ArticleIdList></Reference><Reference><Citation>Lenschow D.J., Giannakopoulos N.V., Gunn L.J., Johnston C., O'Guin A.K., Schmidt R.E., Levine B., Virgin H.W.t. Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J. Virol. 2005;79:13974&#x2013;13983.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1280211</ArticleId><ArticleId IdType="pubmed">16254333</ArticleId></ArticleIdList></Reference><Reference><Citation>Pichlmair A., Reis e Sousa C. Innate recognition of viruses. Immunity. 2007;27:370&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">17892846</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoggins J.W., Rice C.M. Interferon-stimulated genes and their antiviral effector functions. Curr. Opin. Virol. 2011;1:519&#x2013;525.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3274382</ArticleId><ArticleId IdType="pubmed">22328912</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadler A.J., Williams B.R. Interferon-inducible antiviral effectors. Nat. Rev. Immunol. 2008;8:559&#x2013;568.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2522268</ArticleId><ArticleId IdType="pubmed">18575461</ArticleId></ArticleIdList></Reference><Reference><Citation>Gibson G.R., Hutkins R., Sanders M.E., Prescott S.L., Reimer R.A., Salminen S.J., Scott K., Stanton C., Swanson K.S., Cani P.D., Verbeke K., Reid G. Expert consensus document: the International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. Nat. Rev. Gastroenterol. Hepatol. 2017;14:491&#x2013;502.</Citation><ArticleIdList><ArticleId IdType="pubmed">28611480</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottari B., Castellone V., Neviani E. Probiotics and covid-19. Int. J. Food Sci. Nutr. 2021;72:293&#x2013;299.</Citation><ArticleIdList><ArticleId IdType="pubmed">32787470</ArticleId></ArticleIdList></Reference><Reference><Citation>Villena J., Kitazawa H. The modulation of mucosal antiviral immunity by immunobiotics: could they offer any benefit in the SARS-CoV-2 pandemic? Front. Physiol. 2020;11</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7326040</ArticleId><ArticleId IdType="pubmed">32670091</ArticleId></ArticleIdList></Reference><Reference><Citation>Baud D., Dimopoulou Agri V., Gibson G.R., Reid G., Giannoni E. Using probiotics to flatten the curve of coronavirus disease COVID-2019 pandemic. Front. Public Health. 2020;8:186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7227397</ArticleId><ArticleId IdType="pubmed">32574290</ArticleId></ArticleIdList></Reference><Reference><Citation>Maldonado Galdeano C., Cazorla S.I., Lemme Dumit J.M., V&#xe9;lez E., Perdig&#xf3;n G. Beneficial effects of probiotic consumption on the immune system. Ann. Nutr. Metab. 2019;74:115&#x2013;124.</Citation><ArticleIdList><ArticleId IdType="pubmed">30673668</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Q., Dong B.R., Wu T. Cochrane Database Syst Rev.; 2015. Probiotics for Preventing Acute Upper Respiratory Tract Infections.</Citation><ArticleIdList><ArticleId IdType="pubmed">25927096</ArticleId></ArticleIdList></Reference><Reference><Citation>d'Ettorre G., Ceccarelli G., Marazzato M., Campagna G., Pinacchio C., Alessandri F., Ruberto F., Rossi G., Celani L., Scagnolari C., Mastropietro C., Trinchieri V., Recchia G.E., Mauro V., Antonelli G., Pugliese F., Mastroianni C.M. Challenges in the management of SARS-CoV2 infection: the role of oral bacteriotherapy as complementary therapeutic strategy to avoid the progression of COVID-19. Front. Med. 2020;7:389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7358304</ArticleId><ArticleId IdType="pubmed">32733907</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>